Repke, DB; Ferguson, WJ; Bates, DK. Psilocin analogs II. Synthesis of 3-[2-(dialkylamino)ethyl]-, 3-[2-(N-methyl-N-alkylamino)ethyl]-, and 3-[2-(cycloalkylamino)ethyl]indol-4-ols. J. Heterocycl. Chem., 1 Jan 1981, 18 (1), 175–179. 368 kB. https://doi.org/10.1002/jhet.5570180131 #14a
Chapman, SJ. PeakAL: Protons I Have Known and Loved, Too — Another Fifty Shades of Grey-Market Spectra. BLOTTER, 1 Mar 2018, 3 (1). 1.2 MB. https://doi.org/10.16889/isomerdesign-5
Chapman, SJ. PeakAL: Protons I Have Known and Loved, Too — Another Fifty Shades of Grey-Market Spectra. Supplementary Data. BLOTTER, 1 Mar 2018, 3 (1). 5.7 MB. https://doi.org/10.16889/isomerdesign-5-supp
Jacob, P; Shulgin, AT. Structure-activity relationships of the classic hallucinogens and their analogs. In Hallucinogens: An update. NIDA Research Monograph 146; Lin, GC; Glennon, RA, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1 Jan 1994; pp 74–91. 51 kB.
Shulgin, AT. Basic Pharmacology and Effects. In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 24 Apr 2003; pp 67–137. 6.3 MB.
Halberstadt, AL; Chatha, M; Klein, AK; Wallach, J; Brandt, SD. Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. Neuropharmacology, 1 May 2020, 167, 107933. 2.4 MB. https://doi.org/10.1016/j.neuropharm.2019.107933 #4-HO-MPT
Palamar, JJ; Acosta, P. A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines. Hum. Psychopharmacol. Clin. Exp., 1 Jan 2020, 35 (1), e2719. 764 kB. https://doi.org/10.1002/hup.2719 #4-HO-MPT
Klein, AK; Chatha, M; Laskowski, LJ; Anderson, EI; Brandt, SD; Chapman, SJ; McCorvy, JD; Halberstadt, AL. Investigation of the structure–activity relationships of psilocybin analogues. ACS Pharmacol. Transl. Sci., 9 Apr 2021, 4 (2), 533-542. 1.9 MB. https://doi.org/10.1021/acsptsci.0c00176 #4-HO-MPT
Tanaka, R; Kawamura, M; Hakamatsuka, T; Kikura-Hanajiri, R. Identification of six tryptamine derivatives as designer drugs in illegal products. Forensic Toxicol., 1 Jan 2021, 39 (1), 248-258. 997 kB. https://doi.org/10.1007/s11419-020-00556-5 #3 MS,NMR,UV
4-HO-DET · 4-Hydroxy-N,N-diethyltryptamine · CZ-74
4-HO-MIPT · 4-Hydroxy-N-methyl-N-isopropyltryptamine
2-Methyl-5-MeO-DMT · 2-Methyl-5-methoxy-N,N-dimethyltryptamine · 5-MeO-TMT · 5-Methoxy-2-methyl-DMT · MMDT
6-HO-DET · 6-Hydroxy-N,N-diethyltryptamine
5-EtO-DMT · 5-Ethoxy-N,N-dimethyltryptamine · 5-Ethoxy-DMT
7-MeO-NIPT · 7-Methoxy-N-isopropyltryptamine
6-Methyl-5-MeO-DMT · 6-Methyl-5-methoxy-N,N-dimethyltryptamine · 6-Methylbufotenin
5-MeO-α-methyl-DMT · 5-Methoxy-α-methyl-N,N-dimethyltryptamine
1-Isopropyl-5-MeO-T · 1-Isopropyl-5-methoxytryptamine
5-MeO-MET · 5-Methoxy-N-methyl-N-ethyltryptamine
5-MeO-NIPT · 5-Methoxy-N-isopropyltryptamine
7-Methyl-5-MeO-DMT · 7-Methyl-5-methoxy-N,N-dimethyltryptamine
1-Methyl-5-MeO-DMT · 1-Methyl-5-methoxy-N,N-dimethyltryptamine
5-PrO-NMT · 5-Propoxy-N-methyltryptamine
5-IPrO-NMT · 5-Isopropoxy-N-methyltryptamine
N-Methyl-acetyl-norfentanyl
5-HO-MIPT · 5-Hydroxy-N-methyl-N-isopropyltryptamine
4-Hydroxyethyl-N,N-dimethyltryptamine · 4-Hydroxyethyl-DMT
N,N-Diethyltryptamine N-oxide · DET N-oxide
4-HO-NTBT · 4-Hydroxy-N-tert-butyltryptamine
4-HO-NSBT · 4-Hydroxy-N-sec-butyltryptamine
α-HO-DET · α-Hydroxy-N,N-diethyltryptamine
5-MeO-α-methyl-iso-DMT · 5-Methoxy-α-methyl-N,N-dimethyl-isotryptamine · AAZ-A-154
5-IPrO-AMT · 5-Isopropoxy-α-methyltryptamine
4-Methyl-5-MeO-DMT · 4-Methyl-5-methoxy-N,N-dimethyltryptamine
5-HO-DET · 5-Hydroxy-N,N-diethyltryptamine